An overview: Obstructive Sleep Apnea and the Metabolic Syndrome: Should "X" be changed to "Zzz...Zzzz....Zzzzzzzzz....Zzz"?

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 1, Issue 4, 2007, Pages 287-302

  Sadikot, S M ^a  

^a JASLOK HOSPITAL AND RESEARCH CENTRE   (India)

Author keywords

Apnea; Atherosclerotic cardiovascular disease; Metabolic; Sleep; Type 2 DM

Indexed keywords

ANTIHYPERTENSIVE AGENT; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HYPNOTIC AGENT; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; PLACEBO; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANGINA PECTORIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; FATIGUE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HEALTH CARE COST; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; HYPERTENSION; INCIDENCE; INFLAMMATION; INSULIN RESISTANCE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RISK REDUCTION; SLEEP APNEA SYNDROME; SLEEP DISORDER; SNORING; STROKE; THERAPY EFFECT; TRACHEOSTOMY; TRACHEOTOMY;

EID: 35448971347     PISSN: 18714021     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dsx.2007.09.011     Document Type: Review

References (144)

1. Eckel R., Grundy S., and Zimmet P. The metabolic syndrome. Lancet 365 (2005) 1415-1428
2. Grundy S. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 47 (2006) 1093-1100
3. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Available at http://www.idf.org/webdata/docs/IDF_Metasyndrome_definition.pdf Last Accessed August 16, 2006.
4. Grundy S., Cleeman J., Daniels S., Donato K., Eckel R., Franklin B., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112 (2005) 2735-2752
5. Kripke D., Simons R., Garfinkel L., and Hammond E. Short and long sleep and sleeping pills. Is increased mortality associated?. Arch Gen Psychiatry 36 (1979) 103-116
6. Jean-Louis G., Kripke D., and Ancoli-Israel S. Sleep and quality of well-being. Sleep 23 (2000) 1115-1121
7. National Sleep Foundation. 2002 "Sleep in America" Poll (2002), National Sleep Foundation, Washington, DC
8. Bliwise D. Historical change in the report of daytime fatigue. Sleep 19 (1996) 462-464
9. Kahneman D., Krueger A., Schkade D., Schwarz N., and Stone A. A survey method for characterizing daily life experience: the day reconstruction method. Science 306 (2004) 1776-1780
10. Cheyene J. A case of apoplexy, in which the fleshy part of the heart was converted into fat. Dublin Hospital Rep 2 (1818) 216-223
11. Bickelmann A., Burwell C., Robin E., and Whaley R. Extreme obesity associated with alveolar hypoventilation: a Pickwickian syndrome. Am J Med 21 (1956) 811-818
12. Broadbent W. Cheyne-Stokes respiration in cerebral hemorrhage. Lancet 3 (1877) 307-309
13. Breathing disorders in adults, recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine Task Force, Sleep 22 (1999) 667-689.
14. American Academy of Sleep Medicine (AASM). International classification of sleep disorders (2005), AASM, Westchester
15. Vgontzas A., and Kales A. Sleep and its disorders. Annu Rev Med 50 (1999) 387-400
16. Young T., Palta M., Dempsey J., Skatrud J., Weber S., and Badr S. The occurrence of sleep-disordered breathing among middle-age adults. N Engl J Med 328 (1993) 1230-1235
17. Bixler E., Vgontzas A., Ten Have T., Tyson K., and Kales A. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 157 (1998) 144-148
18. Bixler E., Vgontzas A., Lin H., Ten Have T., Rein J., Vela-Bueno A., et al. Prevalence of sleep-disordered breathing in women. Effects of gender. Am J Respir Crit Care Med 163 (2001) 608-613
19. Young T., Peppard P., and Gottlieb D. Epidemiology of obstructive sleep apnea. A population health perspective. Am J Respir Crit Care Med 165 (2002) 1217-1239
20. Young T., Palta M., Dempsey J., Skatrud J., Weber S., and Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328 (1993) 1230-1235
21. Coccagna G., Mantovani M., Brignani F., Parchi C., and Lugaresi E. Tracheostomy in hypersomnia with periodic breathing. Bull Physiopathol Respir (Nancy) 8 (1972) 1217-1227
22. Guilleminault C., Eldridge F., and Dement W. Can an anomaly of the central nervous system be responsible for hemodynamic disorders?. Nouv Presse Med 4 (1975) 1343-1348
23. Guilleminault C., Tilkian A., and Dement W. The sleep apnea syndromes. Annu Rev Med 27 (1976) 465-484
24. Koskenvuo M., Kaprio J., Partinen M., Langinvainio H., Sarna S., and Heikkila K. Snoring as a risk factor for hypertension and angina pectoris. Lancet 1 (1985) 93-96
25. Partinen M., and Guilleminault C. Evolution of obstructive sleep apnea syndrome. In: Guilleminault C., and Partinen M. (Eds). Obstructive sleep apnea syndrome (1990), Raven Press, New York 15-23
26. Partinen M., and Guilleminault C. Daytime sleepiness and vascular morbidity at seven-year follow-up in obstructive sleep apnea patients. Chest 97 (1990) 27-32
27. Pendlebury S., Pepin J., Veale D., and Levy P. Natural evolution of moderate sleep apnoea syndrome: significant progression over a mean of 17 months. Thorax 52 (1997) 872-878
28. Pecker Y., Kraiczi H., Hedner J., Loth S., Johansson A., and Bende M. An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J 14 (1999) 179-184
29. Mooe T., Franklin K., Wiklund U., Rabben T., and Holmstrom K. Sleep-disordered breathing and myocardial ischemia in patients with coronary artery disease. Chest 117 (2000) 1597-1602
30. Mooe T., Rabben T., Wiklund U., Franklin K., and Eriksson P. Sleep-disordered breathing in men with coronary artery disease. Chest 109 (1996) 659-663
31. Mooe T., Rabben T., Wiklund U., Franklin K., and Eriksson P. Sleep-disordered breathing in women: occurrence and association with coronary artery disease. Am J Med 101 (1996) 251-256
32. He J., Kryger M., Zorick F., Conway W., and Roth T. Mortality and apnea index in obstructive sleep apnea. Chest 96 (1988) 480-488
33. Shahar E., Whitney C., Redline S., Lee E., Newman A., Nieto F., et al., Sleep Heart Health Study Research Group. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163 (2001) 19-25
34. Marin J., Carrizo S., Vicente E., and Agusti A. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365 (2005) 1046-1053
35. Peker Y., Hedner J., Norum J., Kraiczi H., and Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 166 (2002) 159-165
36. Zaninelli A., Fariello R., Boni E., Corda L., Alicandri C., and Grassi V. Snoring and risk of cardiovascular disease. Int J Cardiol 32 (1991) 347-351
37. Bassetti C., and Aldrich M. Sleep apnea in acute cerebrovascular diseases: final report on 128 patients. Sleep 22 (1999) 217-223
38. Hung J., Whitford E., Parsons R., and Hillman D. Association of sleep apnoea with myocardial infarction in men. Lancet 336 (1990) 261-264
39. Peker Y., Hedner J., Kraiczi H., and Loth S. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 162 (2000) 81-86
40. D'Alessandro R., Magelli C., Gamberini G., Bachhelli S., Cristina E., Magnani B., et al. Snoring every night as a risk factor for myocardial infarction: a case-control study. BMJ 300 (1990) 1557-1558
41. Dyken M., Somers V., Yamada T., Ren Z., and Zimmerman M. Investigating the relationship between stroke and obstructive sleep apnea. Stroke 27 (1996) 401-407
42. Partinen M. Ischaemic stroke, snoring and obstructive sleep apnoea. J Sleep Res 4 (1995) 156-159
43. Palomaki H., Partinen M., Erkinjuntti T., and Kaste M. Snoring, sleep apnea syndrome, and stroke. Neurology 42 (1992) 75-81
44. Spriggs D., French J., Murdy J., Curless R., Bates D., and James O. Snoring increases the risk of stroke and adversely affects prognosis. QJM 83 (1992) 555-562
45. Williams L., and Holloway R. How much is a good night's sleep worth?. Stroke 36 (2005) 1293-1294
46. Yaggi H., and Mohsenin V. Obstructive sleep apnoea and stroke. Lancet Neurol 3 (2004) 333-342
47. Arzt M., Young T., Finn L., Skatrud J., and Bradley T. Association of sleep disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 172 (2005) 1447-1451
48. Good D., Henkle J., Gelber D., Welsh J., and Verhulst S. Sleep-disordered breathing and poor functional outcome after stroke. Stroke 27 (1996) 252-259
49. Wessendorf T., Dahm C., and Teschler H. Prevalence and clinical importance of sleep apnea in the first night after cerebral infarction. Neurology 60 (2003) 1053
50. Yaggi H., Concato J., Kernan W., Lichtman J., Brass L., and Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353 (2005) 2034-2041
51. Elwood P., Hack M., Pickering J., Hughes J., and Gallacher J. Sleep disturbance, stroke, and heart disease events: evidence from the Caerphilly cohort. J Epidemiol Community Health 60 (2006) 69-73
52. Turkington P., and Elliott M. Sleep disordered breathing following stroke. Monaldi Arch Chest Dis 61 (2004) 157-161
53. Grigg-Damberger M. Why a polysomnogram should become part of the diagnostic evaluation of stroke and transient ischemic attack. J Clin Neurophysiol 23 (2006) 21-38
54. Brown D., Chervin R., Hickenbottom S., Langa K., and Morgenstern L. Screening for obstructive sleep apnea in stroke patients. A cost-effectiveness analysis. Stroke 36 (2005) 1291-1293
55. Partinen M., Jamieson A., and Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients. Mortality. Chest 94 (1988) 1200-1204
56. He J., Kryger M., Zorick F., Conway W., and Roth T. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest 94 (1988) 9-14
57. Lavie P., Lavie L., and Herer P. All-cause mortality in males with sleep apnoea syndrome: declining mortality rates with age. Eur Respir J 25 (2005) 514-520
58. Veale D., Chailleux E., and Hoorelbeke-Ramon A. Mortality of sleep apnoea patients treated by nasal continuous positive airway pressure registered in the ANTADIR observatory. Association Nationale pour le Traitement A Domicile de l'Insuffisance Respiratoire chronique. Eur Respir J 15 (2000) 326-331
59. Marti S., Sampol G., and Munoz X. Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment. Eur Respir J 20 (2002) 1511-1518
60. Campos-Rodriguez F., Pena-Grinan N., Reyes-Nunez N., De La Cruz-Moron I., Perez-Ronchel J., De La Vega-Gallardo F., et al. Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure. Chest 128 (2005) 624-633
61. Haentjens P., Van Meerhaeghe A., Moscariello A., De Weerdt S., Poppe K., Dupont A., et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 167 (2007) 757-764
62. Shamsuzzaman A., Gersh B., and Somers V. Obstructive sleep apnea implications for cardiac and vascular disease. JAMA 290 (2003) 1906-1914
63. Leung R., Bradley T., and Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med 12 (2001) 2147-2165
64. Lattimore J., Celermajer D., and Wilcox I. Obstructive sleep apnea and cardiovascular disease. J Am Coll Cardiol 41 (2003) 1429-1437
65. McNicholas W., Bonsignore M., and Management Committee of EU COST ACTION B26. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 29 (2007) 156-178
66. Quan S, Gersh B, Cardiovascular consequences of sleep-disordered breathing: past, present and future: report of a Workshop from the National Center on Sleep Disorders Research and the National Heart, Lung, and Blood Institute, Circulation 109 (2004) 951-957.
67. Punjabi N., Ahmed M., Polotsky V., Beamer B., and O'Donnell C. Sleep-disordered breathing, glucose intolerance, and insulin resistance. Respir Physiol Neurobiol 136 (2003) 167-178
68. Elmasry A., Janson C., Lindberg E., Gislason T., Tageldin M., and Boman G. The role of habitual snoring and obesity in the development of diabetes: a 10-year follow-up study in a male population. J Intern Med 248 (2000) 13-20
69. Jennum P., Schultz-Larsen K., and Christensen N. Snoring sympathetic activity and cardiovascular risk factors in a 70 year old population. Eur J Epidemiol 9 (1993) 477-482
70. Renko A., Hiltunen L., and Laakso M. The relationship of glucose tolerance to sleep disorders and daytime sleepiness. Diabetes Res Clin Pract 67 (2005) 84-91
71. Shin C., Kim J., Hyeong Kim J., Lee S., Shim J., In K., et al. Association of habitual snoring with glucose and insulin metabolism in nonobese Korean adult men. Am J Respir Crit Care Med 171 (2005) 287-291
72. Elmasry A., Lindberg E., and Berne C. Sleep-disordered breathing and glucose metabolism in hypertensive men, a population-based study. J Intern Med 249 (2001) 153-161
73. Al Delaimy W., Manson J., Willett W., Stampfer M., and Hu F. Snoring as a risk factor for type II diabetes mellitus: a prospective study. Am J Epidemiol 155 (2002) 387-393
74. Gottlieb D., Punjabi N., Newman A., Resnick E., Redline S., Baldwin C., et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med 165 (2005) 863-868
75. Punjabi N., Shahar E., Redline S., Gottlieb D., Givelber R., and Resnick H. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 160 (2004) 521-530
76. Coughlin S., Mawdsley L., Mugarza J., Calverley P., and Wilding J. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 25 (2004) 735-741
77. De La Eva R., Baur L., Donaghue K., and Waters K. Metabolic correlates with obstructive sleep apnea in obese subjects. J Pediatr 140 (2002) 654-659
78. Meslier N., Gagnadoux F., Giraud P., Person C., Ouksel H., Urban T., et al. Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome. Eur Respir J 22 (2003) 156-160
79. Tassone F., Lanfranco F., Gianotti L., Pivetti S., Navone F., Rossetto R., et al. Obstructive sleep apnoea syndrome impairs insulin sensitivity independently of anthropometric variables. Clin Endocrinol (Oxf) 59 (2003) 374-379
80. Ayas N., White D., Al-Delaimy W., Manson J., Stampfer M., Speizer F., et al. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 26 (2003) 380-384
81. Ayas N., White D., Manson J., Stampfer M., Speizer F., Malhotra A., et al. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med 163 (2003) 205-209
82. Yaggi H., Araujo A., and McKinlay J. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care 29 (2006) 657-661
83. Nilsson P., Rööst M., Engström G., Hedblad B., and Berglund G. Incidence of diabetes in middle-aged men is related to sleep disturbances. Diabetes Care 27 (2004) 2464-2469
84. Kawakami N., Takatsuka N., and Shimizu H. Sleep disturbance and onset of type 2 diabetes. Diabetes Care 27 (2004) 282-283
85. The MONICA/KORA Augsburg Cohort Study. Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population. Diabetologia 48 (2005) 235-241
86. Mallon L., Browman J., and Hetta J. High incidence of diabetes in men with sleep complaints or short sleep duration; a 12-year follow-up study of a middle-aged population. Diabetes Care 28 (2005) 2762-2767
87. Björkelund C., Bondyr-Carlsson D., Lapidus L., Lissner L., Månsson J., Skoog I., et al. Sleep disturbances in midlife unrelated to 32-year diabetes incidence: the prospective population study of women in Gothenburg. Diabetes Care 28 (2005) 2739-2744
88. Ip M., Lam B., Ng M., Lam W., Tsang K., and Lam K. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165 (2002) 670-676
89. Punjabi N., Sorkin J., Katzel L., Goldberg A., Schwartz A., and Smith P. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165 (2002) 677-682
90. West S., Nicoll D., and Stradling J. Prevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax 61 (2006) 945-950
91. Reichmuth K., Austin D., Skatrud J., and Young T. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 172 (2005) 1590-1595
92. Chin K., Shimizu K., Nakamura T., Narai N., Masuzaki H., Ogawa Y., et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 100 (1999) 706-712
93. Cooper B., White J., Ashworth L., Alberti K., and Gibson G. Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the acute effects of nasal continuous positive airway pressure (CPAP) treatment. Sleep 18 (1995) 172-179
94. Chin K., Nakamuta T., and Takahashi K. Effects of obstructive sleep apnea syndrome on serum amiotransfease levels in obese patients. Am J Med 114 (2003) 370-376
95. Ip M., Lam K., Ho C., Tsang K., and Lam W. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 118 (2000) 580-586
96. Saini J., Krieger J., Brandenberger G., Wittersheim G., Simon C., and Follenius M. Continuous positive airway pressure treatment. Effects on growth hormone, insulin and glucose profiles in obstructive sleep apnea patients. Horm Metab Res 25 (1993) 375-381
97. Saarelainen S., Lahtela J., and Kallonen E. Effect of nasal CPAP treatment on insulin sensitivity and plasma leptin. J Sleep Res 6 (1997) 146-147
98. Davies R., Turner R., Crosby J., and Stradling J. Plasma insulin and lipid levels in untreated obstructive sleep apnoea and snoring; their comparison with matched controls and response to treatment. J Sleep Res 3 (1994) 180-185
99. Stoohs R., Facchini F., Philip P., Valencia-Flores M., and Guilleminault C. Selected cardiovascular risk factors in patients with obstructive sleep apnea: effect of nasal continuous positive airway pressure (n-CPAP). Sleep 16 (1993) S141-S142
100. West S., Nicoll D., and Wallace T. Obstructive sleep apnoea in men with type 2 diabetes: a double blind randomized controlled trial of the effects of CPAP on HbA1c and insulin resistance. Proc Am Thor Soc 3 (2006) A733
101. Babu A., Herdegen J., Fogelfeld L., Shott S., and Mazzone T. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 165 (2005) 447-452
102. Harsch I., Schahin S., Bruckner K., Radespiel-Troger M., Fuchs F., Hahn E., et al. The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes. Respiration 71 (2004) 252-259
103. Harsch I., Schahin S., Radespiel-Troger M., Weintz O., Jahreiss H., Fuchs F., et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 169 (2004) 156-162
104. Hassaballa H., Tulaimat A., Herdegen J., and Mokhlesi B. The effect of continuous positive airway pressure on glucose control in diabetic patients with severe obstructive sleep apnea. Sleep Breath 9 (2005) 176-180
105. Lindberg E., Berne C., Elmasry A., Hedner J., and Janson C. CPAP treatment of a population-based sample-what are the benefits and the treatment compliance?. Sleep Med 7 (2006) 553-560
106. Brooks B., Cistulli P., Borkman M., Ross G., McGhee S., Grunstein R., et al. Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab 79 (1994) 1681-1685
107. Ip M., and Mokleshi B. Sleep and glucose intolerance/diabetes mellitus. Sleep Med Clin 2 (2007) 19-29
108. Punjabi N., and Polotsky V. Disorders of glucose metabolism in sleep apnea. J Appl Physiol 99 (2005) 1998-2007
109. Spiegel K., Knutson K., Leproult R., Tasali E., and van Cauter E. Sleep loss: a novel risk factor for insulin resistance and type 2 diabetes. J Appl Physiol 99 (2005) 2008-2019
110. Aurora N., and Punjabi N. Sleep apnea and metabolic dysfunction: Cause or Co-Relation?. Sleep Med Clin 2 (2007) 237-250
111. Wilcox I., McNamara S., Collins F., Grunstein R., and Sullivan C. "Syndrome Z": the interaction of sleep apnoea, vascular risk factors and heart disease. Thorax 53 (1998) S25-S28
112. Coughlin S., Calverley P., and Wilding J. Sleep disordered breathing-a new component of syndrome x?. Obes Rev 2 (2001) 267-274
113. Brown L. A waist is a terrible thing to mind: central obesity, the metabolic syndrome, and sleep apnea hypopnea syndrome. Chest 122 (2002) 774-778
114. Vgontzas A., Bixler E., and Chrousos G. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 9 (2005) 211-224
115. Gami A., and Somers V. Obstructive sleep apnoea, metabolic syndrome, and cardiovascular outcomes. Eur Heart J 25 (2004) 709-711
116. Grundy S. Does a diagnosis of metabolic syndrome have value in clinical practice?. Am J Clin Nutr 83 (2006) 1248-1251
117. Zimmet PZ, Alberti G. The metabolic syndrome: perhaps an etiologic mystery but far from a myth-where does the International Diabetes Federation stand? Medscape Diabetes Endocrinol 2005;7(2). Available at: http://www.medscape.com/viewarticle/514211. Accessed July 24th, 2007.
118. Wolk R., and Somers V. Sleep and the metabolic syndrome. Exp Physiol 92 (2006) 67-78
119. Reaven G. The metabolic syndrome: is this diagnosis necessary?. Am J Clin Nutr 83 (2006) 1237-1247
120. Caples S., and Somers V. Sleep, blood pressure regulation, and hypertension. Sleep Med Clin 2 (2007) 77-86
121. Kuniyoshi F., and Somers V. Sleep apnea in hypertension: when, how, and why should we treat?. Hypertension 47 (2006) 818-819
122. Egan B. Sleep and hypertension burning the candle at both ends really is hazardous to your health. Hypertension 47 (2006) 833-839
123. Gangwisch J., Heymsfield S., Boden-Albala B., Buijs R., Kreier F., and Pickering T. Short sleep duration as a risk factor for hypertension: analyses of the First National Health and Nutrition Examination Survey. Hypertension 47 (2006) 833-839
124. Foster G., Poulin M., and Hanly P. Intermittent hypoxia and vascular function: implications for obstructive sleep apnoea. Exp Physiol 92 (2007) 51-65
125. Mahamad S., and Mitchel G. Is there a link between intermittent hypoxia-induced respiratory plasticity and obstructive sleep apnoea?. Exp Physiol 92 (2007) 27-37
126. Weiss J., Liu M., and Huang J. Physiological basis for a causal relationship of obstructive sleep apnoea to hypertension. Exp Physiol 92 (2007) 21-26
127. Smith M., and Pacchia C. Sleep apnoea and hypertension: role of chemoreflexes in humans. Exp Physiol 92 (2007) 45-50
128. Prabhakar N., Dick T., Nanduri J., and Kumar G. Systemic, cellular and molecular analysis of chemoreflex-mediated sympathoexcitation by chronic intermittent hypoxia. Exp Physiol 92 (2007) 39-44
129. Dart R., Gregoire J., Gutterman D., and Woolf S. The association of hypertension and secondary cardiovascular disease with sleep-disordered breathing. Chest 123 (2003) 244-260
130. Brooks D., Horner R., Kozar L., Render-Teixeira C., and Philipson C. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 99 (1997) 1-2
131. García-Río F., Racionero A., Pino J., Martinez I., Ortuño F., Villasante C., et al. Sleep apnea and hypertension the role of peripheral chemoreceptors and the sympathetic system. Chest 117 (2000) 1417-1425
132. Peppard P., Young T., Palta M., and Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342 (2000) 1378-1384
133. Bicklemann A., Burwell C., Robin E., and Whaley R. Extreme obesity associated with alveolar hypoventilation; a Pickwickian syndrome. Am J Med 21 (1956) 811-818
134. Davies R., Ali N., and Stradling J. Neck circumference and other clinical features in the diagnosis of the obstructive sleep apnoea syndrome. Thorax 47 (1992) 101-105
135. Hoffstein V., and Mateika S. Differences in abdominal and neck circumferences in patients with and without obstructive sleep apnoea. Eur Respir J 5 (1992) 377-381
136. Levinson P., McGarvey S., Carlisle C., Eveloff S., Herbert P., and Millman R. Adiposity and cardiovascular risk factors in men with obstructive sleep apnea. Chest 103 (1993) 1336-1342
137. Grunstein R., Wilcox I., and Yang T. Snoring and sleep apnea in men: interaction with central obesity and hypertension. Int J Obes 17 (1993) 533-540
138. Strobel R., and Rosen R. Obesity and weight loss in obstructive sleep apnea: a critical review. Sleep 19 (1996) 104-115
139. Brown L. A waist is a terrible thing to mind central obesity, the metabolic syndrome, and sleep apnea hypopnea syndrome. Chest 122 (2002) 774-778
140. Young T., Peppard P., and Taheri S. Excess weight and sleep-disordered breathing. J Appl Physiol 99 (2005) 1592-1599
141. Stradling J. Sleep apnea does not cause cardiovascular disease. Am J Respir Crit Care Med 169 (2004) 148-149
142. Nieto F., Young T., Lind B., Shahar E., Samet J., Redline S., et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study: Sleep Heart Health Study. JAMA 283 (2000) 1829-1836
143. Kiely J., and McNicholas W. Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. Eur Respir J 16 (2000) 128-133
144. Ip M. Obstructive sleep apnoea: What is the evidence for vascular pathogenesis?. Respirology 12 (2007) 12-14